Lord, Abbett & Co. LLC 10x Genomics, Inc. Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 07, 2024	SELL	$34.32 - $57.55 $12.6 Million - $21.1 Million	-365,959 Reduced 47.22%	409,127 $22.9 Million
Q4 2023 Feb 12, 2024	SELL	$34.32 - $57.55 $12.6 Million - $21.1 Million	-365,959 Reduced 47.22%	409,127 $22.9 Million
Q3 2023 Oct 07, 2024	SELL	$40.86 - $62.98 $19.7 Million - $30.3 Million	-481,240 Reduced 38.31%	775,086 $32 Million
Q3 2023 Nov 13, 2023	SELL	$40.86 - $62.98 $19.7 Million - $30.3 Million	-481,240 Reduced 38.31%	775,086 $32 Million
Q2 2023 Oct 07, 2024	BUY	$50.96 - $58.72 $10.5 Million - $12.1 Million	206,237 Added 19.64%	1,256,326 $70.2 Million
Q2 2023 Aug 14, 2023	BUY	$50.96 - $58.72 $10.5 Million - $12.1 Million	206,237 Added 19.64%	1,256,326 $70.2 Million
Q1 2023 Oct 07, 2024	BUY	$35.33 - $55.79 $37.1 Million - $58.6 Million	1,050,089 New	1,050,089 $58.6 Million
Q1 2023 May 12, 2023	BUY	$35.33 - $55.79 $37.1 Million - $58.6 Million	1,050,089 New	1,050,089 $58.6 Million
Q2 2022 Aug 12, 2022	SELL	$36.95 - $82.41 $2.19 Million - $4.88 Million	-59,159 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$55.7 - $145.79 $1.48 Million - $3.86 Million	-26,483 Reduced 30.92%	59,159 $4.5 Million
Q4 2021 Feb 11, 2022	BUY	$135.05 - $182.59 $4.92 Million - $6.65 Million	36,403 Added 73.93%	85,642 $12.8 Million
Q3 2021 Nov 09, 2021	BUY	$145.58 - $192.14 $1.15 Million - $1.52 Million	7,891 Added 19.08%	49,239 $7.17 Million
Q2 2021 Aug 11, 2021	SELL	$134.22 - $202.37 $43.1 Million - $64.9 Million	-320,798 Reduced 88.58%	41,348 $8.1 Million
Q1 2021 May 11, 2021	SELL	$140.25 - $196.86 $30.3 Million - $42.5 Million	-216,080 Reduced 37.37%	362,146 $65.5 Million
Q4 2020 Feb 09, 2021	BUY	$126.47 - $163.7 $10.3 Million - $13.3 Million	81,421 Added 16.39%	578,226 $81.9 Million
Q3 2020 Nov 12, 2020	SELL	$87.44 - $125.0 $2.74 Million - $3.91 Million	-31,298 Reduced 5.93%	496,805 $61.9 Million
Q2 2020 Aug 14, 2020	SELL	$58.39 - $89.31 $15.2 Million - $23.3 Million	-260,988 Reduced 33.07%	528,103 $47.2 Million
Q1 2020 May 14, 2020	BUY	$51.57 - $106.62 $6.98 Million - $14.4 Million	135,256 Added 20.69%	789,091 $49.2 Million
Q4 2019 Feb 14, 2020	SELL	$46.07 - $79.54 $3.65 Million - $6.31 Million	-79,289 Reduced 10.82%	653,835 $49.9 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $36.6 Million - $45.5 Million	733,124 New	733,124 $36.9 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

Vanguard Group Inc Valley Forge, PA

11M
Shares

$174 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

10.8M
Shares

$170 Million
2.31% of portfolio
Morgan Stanley New York, NY

6.48M
Shares

$102 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.39M
Shares

$101 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

6.37M
Shares

$101 Million
1.67% of portfolio

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account